Compugen Ltd. Cost of Revenue 2011-2026 | CGEN

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue Compugen Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
7.93 M	2 M	975 K	680 K	60 K	-	1.03 M	-	223 K	1.63 M	3.34 M	2.51 M	201 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.93 M	60 K	1.87 M

Cost of Revenue of other stocks in the Biotechnology industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Biogen BIIB	2.31 B	$ 173.17	0.92 %	$ 25.2 B	USA
MorphoSys AG MOR	32.2 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	15.3 M	-	-24.86 %	$ 820 K	USA
BioNTech SE BNTX	2.91 B	$ 117.62	1.41 %	$ 27.2 B	Germany
Aptorum Group Limited APM	421 K	$ 0.98	1.35 %	$ 5.34 M	China
Catalyst Biosciences CBIO	4.64 M	$ 11.66	-8.95 %	$ 768 M	USA
Midatech Pharma plc MTP	926 K	-	-18.52 %	$ 27.3 M	Britain
BioXcel Therapeutics BTAI	2.14 M	$ 1.77	-2.75 %	$ 4.49 M	USA
Cellectis S.A. CLLS	31.4 M	$ 4.13	-6.56 %	$ 116 M	France
Ascendis Pharma A/S ASND	3.52 M	$ 233.49	-0.81 %	$ 5 B	Danmark
Acasti Pharma ACST	76 K	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	17.3 M	$ 67.41	0.54 %	$ 9.02 B	USA
Aeterna Zentaris AEZS	90 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	40 K	-	-10.17 %	$ 12.2 K	USA
Amphastar Pharmaceuticals AMPH	358 M	$ 26.57	2.51 %	$ 1.29 B	USA
Coherus BioSciences CHRS	159 M	$ 2.26	9.7 %	$ 213 M	USA
Amneal Pharmaceuticals AMRX	1.77 B	$ 13.59	1.46 %	$ 4.2 B	USA
AIkido Pharma AIKI	9 K	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.36 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	238 M	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	369 K	-	-11.43 %	$ 502 K	USA
Celldex Therapeutics CLDX	200 K	$ 26.72	3.09 %	$ 1.72 M	USA
Ayala Pharmaceuticals AYLA	602 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	20.6 M	$ 2.75	1.85 %	$ 17.3 M	USA
AstraZeneca PLC AZN	12.4 B	$ 94.24	1.38 %	$ 96.9 B	Britain